1. Home
  2. IMRN vs GURE Comparison

IMRN vs GURE Comparison

Compare IMRN & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • GURE
  • Stock Information
  • Founded
  • IMRN 1994
  • GURE 2006
  • Country
  • IMRN Australia
  • GURE China
  • Employees
  • IMRN N/A
  • GURE N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • GURE Major Chemicals
  • Sector
  • IMRN Health Care
  • GURE Industrials
  • Exchange
  • IMRN Nasdaq
  • GURE Nasdaq
  • Market Cap
  • IMRN 9.2M
  • GURE 8.7M
  • IPO Year
  • IMRN N/A
  • GURE 1992
  • Fundamental
  • Price
  • IMRN $1.81
  • GURE $0.68
  • Analyst Decision
  • IMRN Strong Buy
  • GURE
  • Analyst Count
  • IMRN 1
  • GURE 0
  • Target Price
  • IMRN $5.00
  • GURE N/A
  • AVG Volume (30 Days)
  • IMRN 82.1K
  • GURE 43.1K
  • Earning Date
  • IMRN 09-08-2025
  • GURE 08-13-2025
  • Dividend Yield
  • IMRN N/A
  • GURE N/A
  • EPS Growth
  • IMRN N/A
  • GURE N/A
  • EPS
  • IMRN N/A
  • GURE N/A
  • Revenue
  • IMRN $4,048,286.00
  • GURE $13,919,011.00
  • Revenue This Year
  • IMRN N/A
  • GURE N/A
  • Revenue Next Year
  • IMRN N/A
  • GURE N/A
  • P/E Ratio
  • IMRN N/A
  • GURE N/A
  • Revenue Growth
  • IMRN 82.90
  • GURE N/A
  • 52 Week Low
  • IMRN $1.50
  • GURE $0.50
  • 52 Week High
  • IMRN $2.87
  • GURE $1.47
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.51
  • GURE 55.02
  • Support Level
  • IMRN $1.62
  • GURE $0.60
  • Resistance Level
  • IMRN $1.84
  • GURE $0.65
  • Average True Range (ATR)
  • IMRN 0.09
  • GURE 0.04
  • MACD
  • IMRN 0.02
  • GURE 0.00
  • Stochastic Oscillator
  • IMRN 89.55
  • GURE 66.67

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: